Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17868433 | 1.00 | USP7 (0.78) | USP7USP19 | |
| SCHEMBL17868434 | 1.00 | USP7 (0.78) | USP7USP19 | |
| SCHEMBL17868543 | 0.92 | USP7 (0.75) | USP7USP19 | |
| SCHEMBL17868542 | 0.92 | USP7 (0.75) | USP7USP19 | |
| SCHEMBL17868484 | 0.88 | USP7 (1.00) | USP7USP19 | |
| SCHEMBL17868508 | 0.87 | USP7 (1.00) | USP7USP19 | |
| SCHEMBL17868408 | 0.83 | USP7 (0.76) | USP7USP19 | |
| SCHEMBL17868398 | 0.83 | USP7 (0.76) | USP7USP19 | |
| SCHEMBL20864562 | 0.81 | USP7 (0.80) | USP7USP19 | |
| SCHEMBL17966254 | 0.81 | USP7 (0.80) | USP7USP19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220125760-A1 | USE OF USP7 INHIBITORS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) | UNIVERSITÉ PAUL SABATIER TOULOUSE III (FR) | 2022-04-28 | — | — | US | disclosed |